Inhibition of angiogenesis as a strategy for tumor growth control
β Scribed by Herblin, William F. ;Gross, Janet L.
- Publisher
- Springer-Verlag
- Year
- 1994
- Tongue
- English
- Weight
- 458 KB
- Volume
- 21
- Category
- Article
- ISSN
- 1044-7393
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Cancers have a formidahle capacity to develop resistance to a large and diverse array of chemical, biologic, and physical anti-neoplastic agents. This can be largely traced to the instability of the tumor cell genome, and the resultant ability of tumor cell populations to generate phenotypic variant
## Abstract __Ocimum__ sp. is a traditionally used medicinal herb, which shows antiβoxidant, antiβcarcinogenic, radioβprotective and free radical scavenging properties. So far no detailed studies have been reported on its effects on human cancers. Thus, we analyzed its effects on human breast cance
Polyamines are essential in various biological systems such as cellular proliferation including tumor growth, differentiation and neoplastic transformation including carcinogenesis. β£-Difluoromethylornithine (DFMO) is a specific irreversible inhibitor of ornithine decarboxylase, a key enzyme in poly
Recently, we reported a novel protein of the tumor necrosis factor (TNF) superfamily, named vascular endothelial cell growth inhibitor (VEGI), which is expressed predominantly in endothelial cells. When a secreted form of this new protein was overexpressed in mouse colon cancer cells, the growth of